This compound is a chiral pharmaceutical intermediate featuring a fused cyclopenta[b]furan ring system with a tert-butyldimethylsilyl ether protecting group. It is primarily significant as a key synthetic building block in the preparation of prostaglandins.
نطاق المحتوى: تتعلق المعلومات الواردة في هذه الصفحة بتحديد المواد الكيميائية وبسياقات التوريد الصناعي والبحث والإنتاج. وهي لا تشكّل ادعاءً علاجياً أو نصيحة طبية أو إرشادات لاستخدام الأدوية.
هل تشتري أو تورد هذا المركب؟
أضف مخزونك أو أنشر طلب شراء
CAS 64072-25-9
(3aR,4R,5R,6aS)-5-((tert-Butyldimethylsilyl)oxy)-4-((S,E)-3-hydroxyoct-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-2-one
Prostaglandin intermediate
(1,1'-Biphenyl)-4-carboxylic acid, (3aR,4S,5R,6aS)-hexahydro-4-(hydroxymethyl)-2-oxo-2H-cyclopenta(b)furan-5-yl ester
Pharmaceutical intermediate for prostaglandin synthesis
Tetrahydro-2H-thiopyran-4-carboxylic acid 1,1-dioxide
pharmaceutical intermediate
2-Fluoro-5-methylbenzonitrile
Pharmaceutical intermediate
4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid
Nilotinib intermediate
Ethyl 3-Carbamimidoylamino-4-methylbenzoate Nitrate
pharmaceutical intermediate
(3aR,4R,5R,6aS)-Hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-1-octen-1-yl]-2H-cyclopenta[b]furan-2-one
Prostaglandin research compound
(3aR,4S,5R,6aS)-hexahydro-5-hydroxy-4-(hydroxymethyl)-2H-cyclopenta[b]furan-2-one
prostaglandin synthesis intermediate
(3aR,4R,5R,6aS)-5-[tert-butyl(dimethyl)silyl]oxy-4-[(E)-3-oxooct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-one
RUMJJBFTZIDROK-KXCTWPOZSA-N
CCCCCC(=O)/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1CC(=O)O2)O[Si](C)(C)C(C)(C)C
—